Endonovo Therapeutics Inc (ENDV): h. Trading Limitations . The Buyer shall...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

Endonovo Therapeutics Inc (ENDV)

Reply Private New

Keep Last Read

Next 10 Prev Next

Send PM Follow Ignore

Followers	3
Posts	231
Boards Moderated	0
Alias Born	06/03/2016

Re: None

Monday, 04/17/2017 8:01:34 AM

Monday, April 17, 2017 8:01:34 AM

h. Trading Limitations . The Buyer shall limit is sales of Common Stock convertible under this Note (“Convertible Shares”) such that in no single trading day shall the Buyer sell Convertible Shares in excess of the greater of $10,000 or 20% of the aggregate trading volume of the Company Common Stock on that trading day all sales shall be made through one broker/dealer and the trading limitation shall be acknowledged by Buyer’s broker/dealer.

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent ENDV News

Form 15-12G - Securities registration termination [Section 12(g)] • Edgar (US Regulatory) • 02/02/2024 10:23:02 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/03/2024 10:30:14 PM
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend] • Edgar (US Regulatory) • 12/29/2023 08:20:36 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/04/2023 02:08:41 PM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 05:21:48 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/12/2023 10:03:32 AM
Form 1-A/A - Offering Statement [Regulation A]: [Amend] • Edgar (US Regulatory) • 08/25/2023 11:04:33 AM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/21/2023 09:16:04 PM

More ENDV News

InvestorsHub NewsWire

FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow